Gabrielle Fröberg

Publications
CV
Public outreach and news

Articles

Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023;67(10):e0052823-e00523

The in vitro effecteffect of new combinations of carbapenem-ßlactamase inhibitors for MycobacteriumabscessusMycobacterium abscessus

Froberg G; Ahmed A; Chryssanthou E; Davies Forsman L
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2023;29(6):758-764

Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

Froberg G; Maurer FP; Chryssanthou E; Fernstrom L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyrylainen H-L; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schon T
Article: JOURNAL OF INFECTIOUS DISEASES. 2023;227(6):820-827

A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome

Hedin W; Froberg G; Fredman K; Chryssanthou E; Selmeryd I; Gillman A; Orsini L; Runold M; Joensson B; Schon T; Forsman LD
Article: ISCIENCE. 2022;25(12):105652

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis

Mousavian Z; Folkesson E; Froberg G; Foroogh F; Correia-Neves M; Bruchfeld J; Kallenius G; Sundling C
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:727300

High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids

Silva CS; Sundling C; Folkesson E; Froberg G; Nobrega C; Canto-Gomes J; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Kallenius G
Article: TUBERCULOSIS. 2020;123:101959

CD4⁺ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection

Borgstrom EW; Froberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Angeby K; Tecleab T; Ruhwald M; Andersen P; Kallenius G; Bruchfeld J
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1900851

Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017

Froberg G; Jansson L; Nyberg K; Obasi B; Westling K; Berggren I; Bruchfeld J
Article: ERJ OPEN RESEARCH. 2019;5(2):78-2019

A new mathematical model to identify contacts with recent and remote latent tuberculosis

Froberg G; Borgstrom EW; Chryssanthou E; Correia-Neves M; Kallenius G; Bruchfeld J
Article: INFECTION GENETICS AND EVOLUTION. 2015;33:110-117

Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013

Morris U; Xu W; Msellem MI; Schwartz A; Abass A; Shakely D; Cook J; Bhattarai A; Petzold M; Greenhouse B; Ali AS; Bjorkman A; Froberg G; Martensson A
Article: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2014;91(4):833-843

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine

Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Martensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guerin P; Davis TME; Menard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Bjorkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimde AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher J-F; Froberg G; Grivoyannis A; Hamour S; Houze S; Johnson J; Kamugisha E; Kariuki S; Kiechel J-R; Kironde F; Kofoed P-E; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouedraogo J-B; Piola P; Rombo L; Schramm B; Some AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH
Article: ANNALS OF INTERNAL MEDICINE. 2013;158(6):456-468

GeoSentinel Surveillance of Illness in Returned Travelers, 2007-2011

Leder K; Torresi J; Libman MD; Cramer JP; Castelli F; Schlagenhauf P; Wilder-Smith A; Wilson ME; Keystone JS; Schwartz E; Barnett ED; von Sonnenburg F; Brownstein JS; Cheng AC; Sotir MJ; Esposito DH; Freedman DO
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013;57(2):887-892

Assessing the Cost-Benefit Effect of a Plasmodium falciparum Drug Resistance Mutation on Parasite Growth In Vitro

Froberg G; Ferreira PE; Martensson A; Ali A; Bjorkman A; Gil JP
Article: MALARIA JOURNAL. 2012;11:321

Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar

Froberg G; Jornhagen L; Morris U; Shakely D; Msellem MI; Gil JP; Bjorkman A; Martensson A
Article: PLOS ONE. 2011;6(9):e23875

PfMDR1: Mechanisms of Transport Modulation by Functional Polymorphisms

Ferreira PE; Holmgren G; Veiga MI; Uhlen P; Kaneko A; Gil JP
Article: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2007;77(6):1034-1038

Short report:: Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to arnodiaquine and desethylarnodiaquine

Echeverry DF; Holmgren G; Murillo C; Higuita JC; Bjorkman A; Gil JP; Osorio L
Article: INFECTION GENETICS AND EVOLUTION. 2007;7(5):562-569

Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa

Holmgren G; Hamrin J; Svard J; Martensson A; Gil JP; Bjorkman A
Article: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2006;11(12):1808-1812

Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya

Holmgren G; Bjorkman A; Gil JP
Article: INFECTION GENETICS AND EVOLUTION. 2006;6(4):309-314

Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y

Holmgren G; Gil JP; Ferreira PM; Veiga MI; Obonyo CO; Björkman A

All other publications

Review: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2023;12(3):211-225

The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review

Andersson V; Froberg G; Dahl V; Chryssanthou E; Giske C; Schon T; Forsman L
Preprint: MEDRXIV. 2022

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis

Mousavian Z; Folkesson E; Fröberg G; Foroogh F; Correia-Neves M; Bruchfeld J; Källenius G; Sundling C
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2022;52:15

Network-based analysis reveals a plasma protein signature associated with active tuberculosis

Mousavian Z; Folkesson E; Froberg G; Foroogh F; Correia-Neves M; Goletti D; Bruchfeld J; Kallenius G; Sundling C
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2022;52:29

Individuals with active and latent Tuberculosis have distinct NK cell function

Silva CS; Folkesson E; Froberg G; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Correia-Neves M; Kallenius G; Sundling C
Preprint: BIORXIV. 2021

Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB

Silva C; Sundling C; Folkeson E; Fröberg G; Nobrega C; Canto-Gomes J; Chambers B; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Källenius G
Book chapter: ESSENTIAL TUBERCULOSIS. 2021;p. 259-266

Extrapulmonary Tuberculosis

Bruchfeld J; Forsman LD; Fröberg G; Niward K
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:297

Stimulation with mycobacterial glycolipids reveals different innate immune response profiles in active and latent tuberculosis

Silva CS; Sundling C; Folkesson E; Froberg G; Nobrega C; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Neves MC; Kallenius G
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(6)

Stimulation with mycobacterial glycolipids reveals different innate immune response profiles in active and latent Tuberculosis

Silva C; Sundling C; Folkesson E; Froberg G; Nobrega C; Canto--Gomes J; Chambers B; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Kallenius G
Letter: EUROPEAN RESPIRATORY JOURNAL. 2019;53(2):1801128

Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice

Froberg G; Jansson L; Bruchfeld J
Review: ERJ OPEN RESEARCH. 2019;5(1):115-2018

Biomarkers for tuberculosis: the case for lipoarabinomannan

Correia-Neves M; Froberg G; Korshun L; Viegas S; Vaz P; Ramanlal N; Bruchfeld J; Hamasur B; Brennan P; Kallenius G
Conference publication: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2015;20:185-186

How is Plasmodium falciparum parasite invitro growth fitness affected by drug resistance associated Pfcrt mutations?

Schmidt BA; Bjorkman A; Froberg G
Letter: JOURNAL OF INFECTIOUS DISEASES. 2013;207(4):687-688

CYP2C8 Status of Patients With Malaria Influences Selection of Plasmodium falciparum pfmdr1 Alleles After Amodiaquine-Artesunate Treatment

Cavaco I; Martensson A; Froberg G; Msellem M; Bjorkman A; Gil JP
Thesis / dissertation: 2010

Plasmodium falciparum resistance to amodiaquine in monotherapy and in combination therapy with artesunate

Holmgren, Gabrielle

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2024-2027

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2010
University Medical Degree, Karolinska Institutet, 1997

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI